---
title: "Versant Venture Capital VI, L.P. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/404ee6ec-7cde-5398-8809-bbf45932b5b8
json: https://whiteintel.dev/api/public/dossier/404ee6ec-7cde-5398-8809-bbf45932b5b8
identifier: sec:0001687880
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Versant Venture Capital VI, L.P.

**Type:** Person  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001687880`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/404ee6ec-7cde-5398-8809-bbf45932b5b8  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/404ee6ec-7cde-5398-8809-bbf45932b5b8  

## Ownership & control

### Holdings / subsidiaries

- **LAVA Therapeutics NV** (10% owner) — https://whiteintel.dev/entity/8808543c-df76-5e16-a8ad-fc1298aabc0d
- **LENZ Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/52024eeb-7411-50be-bf00-889ef1323af1
- **LAVA Therapeutics NV** (tenpercentowner) — https://whiteintel.dev/entity/8808543c-df76-5e16-a8ad-fc1298aabc0d
- **Monte Rosa Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/2502d2d3-36f0-5a79-9054-73089f53017a
- **Tempest Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/0c3b95ca-716e-5b66-a863-b0f8a59c274c
- **Black Diamond Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/eebeac84-4ec0-5c45-a922-3876ecea7a84
- **Contineum Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/133dd096-0412-55dd-9c60-de26ff4eae33
- **OYSTER POINT PHARMA, INC.** (tenpercentowner) — https://whiteintel.dev/entity/5e6eb1ea-5893-580d-adfb-09d9a3272164
- **Century Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/322aed2c-be71-5c5d-a3b2-2fb2fb031454
- **Repare Therapeutics Inc.** (tenpercentowner) — https://whiteintel.dev/entity/a4f328c3-615d-5e8c-a160-a31e92a6143d
- **Aligos Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/15206969-c284-5758-b9c6-6d6ff804a67a
- **Akero Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/1f3a658e-849c-5eb6-bb63-c6eefc0a7b8b
- **PANDION THERAPEUTICS HOLDCO LLC** (tenpercentowner) — https://whiteintel.dev/entity/060b1392-136a-5cbf-a2ea-51a04af26d41
- **Passage BIO, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/3797b803-565f-56ce-9606-f58967c79f6d

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Versant Venture Capital VI, L.P.**. Human view: https://whiteintel.dev/entity/404ee6ec-7cde-5398-8809-bbf45932b5b8 · Structured JSON: https://whiteintel.dev/api/public/dossier/404ee6ec-7cde-5398-8809-bbf45932b5b8._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._